Gongdong Medical: Announcement on using idle own funds to purchase financial products
Securities code: 605369 Securities abbreviation: Gongdong Medical Announcement number: 2026-007 Zhejiang Gongdong Medical Equipment Co., Ltd.
Announcement on using idle own funds to purchase financial products
The company's board of directors and all directors guarantee that the contents of this announcement do not contain any false records, misleading statements or major omissions, and assume legal responsibility for the authenticity, accuracy and completeness of its contents.
Important content reminder:
Basic situation
The maximum balance in a single day shall not exceed RMB 1 billion. Within this limit, Zhejiang Gongdong Medical Investment Equipment Co., Ltd. (hereinafter referred to as the "Company") and its subsidiaries (including wholly-owned subsidiaries)
and holding subsidiaries, the same below) will be used on a rolling basis.
Investment types: Financial products sold by financial institutions with high security, good liquidity and legal operating qualifications Fund sources: Own funds
Review procedures performed and planned to be performed
On April 23, 2026, the 20th meeting of the company's third board of directors reviewed and approved the "Proposal on Using Idle Own Funds to Purchase Financial Management Products". This matter still needs to be submitted to the company's shareholders' meeting for review.
Special risk warning
When companies purchase financial products, although in principle they will choose financial products with high security and good liquidity, the financial market is greatly affected by factors such as the macroeconomic environment, fiscal and monetary policies, and the products may cause income fluctuations due to interest rate risks, liquidity risks, policy risks, etc. Investors are kindly requested to pay attention to investment risks.
1. Overview of investment situation
(1) Investment purpose
In order to improve the efficiency of the company's capital use, rationally utilize idle self-owned funds, and increase investment income for the company and shareholders while ensuring the liquidity required for normal operations.
(2) Investment amount
It is planned to use idle self-owned funds with a maximum single-day balance of no more than RMB 1 billion. Within this limit, the company and its subsidiaries will jointly use it on a rolling basis.
(3) Source of funds
The company and its subsidiaries have idle own funds.
(4) Investment methods
The company will strictly control risks in accordance with relevant regulations and use part of its temporarily idle own funds to purchase financial products sold by financial institutions with high security, good liquidity and legal operating qualifications.
(5) Investment period
From the date of approval by the 2025 annual shareholders' meeting to the date of the 2026 annual shareholders' meeting, in principle, it shall not exceed 12 months.
2. Review procedure
This matter was reviewed and approved at the 20th meeting of the company's third board of directors. It still needs to be submitted to the company's shareholders' meeting for review, and the shareholders' meeting is requested to authorize the chairman and his authorized person to exercise decision-making power within the above-mentioned quota range and period, and to sign or authorize others to sign relevant agreements and documents, etc.
3. Investment risk analysis and risk control measures
(1) Investment risk analysis
When companies purchase financial products, although in principle they will choose financial products with high security and good liquidity, the financial market is greatly affected by factors such as the macroeconomic environment, fiscal and monetary policies, and the products may cause income fluctuations due to interest rate risks, liquidity risks, policy risks, etc. Investors are kindly requested to pay attention to investment risks.
(2) Risk control measures
When companies choose financial products, they should choose financial products sold by financial institutions with high security, good liquidity and legal business qualifications, which have low investment risks.
When the company's financial department is responsible for the specific implementation, it will establish a ledger to track and analyze the investment direction and progress of financial products in real time. Once it is discovered or judged that there are factors that may affect the income of financial products, corresponding preservation measures will be taken in a timely manner to control investment risks to the maximum extent.
Independent directors have the right to supervise and inspect the use of funds, and can hire professional institutions to conduct audits when necessary.
4. Impact of investment on the company
The company plans to use idle self-owned funds to purchase financial products this time, under the premise of ensuring that it does not affect the normal development of the company's main business and ensures daily operating capital needs and capital security. Reasonable use of idle self-owned funds to purchase financial products can obtain certain investment returns, which is conducive to improving the efficiency of capital use without harming the interests of the company and shareholders.
Announcement is hereby made.
Board of Directors of Zhejiang Gongdong Medical Equipment Co., Ltd.
April 24, 2026